Status:
COMPLETED
The Role of Glucocorticoid Receptor SNPs in Receptor Function and Metabolic Disease
Lead Sponsor:
National Institute of Environmental Health Sciences (NIEHS)
Conditions:
Glucose Homeostasis
Protein Metabolism
Eligibility:
All Genders
18-100 years
Brief Summary
Background: \- Glucocorticoids are primary stress response hormones released from the adrenal gland when an individual is under stress. Chronic or ongoing elevation of these hormones due to prolonged...
Detailed Description
STUDY DESIGN: This in vivo and in vitro observational gene association study will investigate the functional relevance of SNPs in the NR3C1 gene in selected populations. A subgroup of the EPR will be...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA FOR PART 1 AND 2:
- Male or female 18 years of age or older at the time of enrollment
- Must be a participant in the EPR study
- Are genotyped and determined to be heterozygote or homozygote carriers of one of the two hGR SNPs (hGR9B A3669G and hGR N363S) or are wild type at the SNP location
- Able to understand and provide written informed consent to participate in the study
- Able to travel to the CRU
- Willing and able to fast for periods of up to 12 hours during the study
- Healthy participants as defined by the International Red Cross guidelines (Healthy means that an individual feels well and can perform normal activities. If the individual has a chronic condition such as diabetes or high blood pressure, healthy also means that they are being treated and the condition is under control).
- EXCLUSION CRITERIA:
- Exclusion Criteria for Part 1
- Participants with the following history will be excluded from part 1 of the study:
- Any glucocorticoid use within approximately 14 days of scheduled visit 1 including oral, inhaled, nasal sprays, and cream (dermal/mucosal)
- Pregnant or currently breastfeeding
- Planning to use certain medications because they can affect test results.
- Any condition that, in the investigator's opinion, places the participant at undue risk for complications.
- Exclusion Criteria for Part 2
- Participants with the following history will be excluded from part 2 of the study to avoid confounding the dexamethasone suppression test:
- Any glucocorticoid use within approximately 14 days of scheduled visit 2 including oral, inhaled, nasal sprays, and cream (dermal/mucosal)
- Pregnant or currently breastfeeding
- Currently enrolled in another clinical research study and/or is receiving an investigational agent for any reason
- Does not agree to take dexamethasone at scheduled time
- Planning to use certain medications such as corticosteroids, estrogens, or tetracyclines prior to the visit 2, because they can affect test results. If the participant is willing to withhold these medications for 14 days, then the participant will be allowed to participate in visit 2.
- Participants with the following history will be excluded from part 2 of the study because the dexamethasone may cause potential harm to the participant:
- High blood pressure of 160/10 mm Hg or above.
- Active coronary artery disease (angina) or moderate to severe heart failure stage New York Heart Association III-IV
- Renal failure
- Glaucoma
- Uncontrolled psychiatric disorders such as bipolar disorder or schizoaffective disorder
- Active systemic fungal infection
- Prior hypersensitivity reaction to Dexamethasone
- Currently receiving treatment for cancer (certain cancers, like lung cancer make adrenocorticotropic hormone (ACTH), and all induce stress)
- Any condition that, in the investigator's opinion, places the participant at undue risk for complications
Exclusion
Key Trial Info
Start Date :
September 30 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 2 2019
Estimated Enrollment :
278 Patients enrolled
Trial Details
Trial ID
NCT01143493
Start Date
September 30 2010
End Date
December 2 2019
Last Update
December 4 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NIEHS Clinical Research Unit (CRU)
Research Triangle Park, North Carolina, United States